相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Treatment of metastatic renal cell carcinoma
Maxine Sun et al.
NATURE REVIEWS UROLOGY (2010)
Impact of C-Reactive Protein Kinetics on Survival of Patients with Metastatic Renal Cell Carcinoma
Kazutaka Saito et al.
EUROPEAN UROLOGY (2009)
Sorafenib for Treatment of Renal Cell Carcinoma: Final Efficacy and Safety Results of the Phase III Treatment Approaches in Renal Cancer Global Evaluation Trial
Bernard Escudier et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma
Robert J. Motzer et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
In Situ Cytotoxic and Memory T Cells Predict Outcome in Patients With Early-Stage Colorectal Cancer
Franck Pages et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Prognostic implications of type and density of tumour-infiltrating lymphocytes in gastric cancer
H. E. Lee et al.
BRITISH JOURNAL OF CANCER (2008)
Loss of CTL function among high-avidity tumor-specific CD8+ T cells following tumor infiltration
Claire N. Janicki et al.
CANCER RESEARCH (2008)
Impact of tumor-infiltrating T cells on survival in patients with malignant pleural mesothelioma
Masaki Anraku et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2008)
Prognostic impact of postoperative C-reactive protein level in patients with metastatic renal cell carcinoma undergoing cytoreductive nephrectomy
Manabu Tatokoro et al.
JOURNAL OF UROLOGY (2008)
C-reactive protein is an informative predictor of renal cell carcinoma-specific mortality - A European study of 313 patients
Pierre I. Karakiewicz et al.
CANCER (2007)
PD-1 is expressed by tumor-infiltrating immune cells and is associated with poor outcome for patients with renal cell carcinoma
R. Houston Thompson et al.
CLINICAL CANCER RESEARCH (2007)
Type, density, and location of immune cells within human colorectal tumors predict clinical outcome
Jerom Galon et al.
SCIENCE (2006)
Mononuclear cell infiltration in clear-cell renal cell carcinoma independently predicts patient survival
W. Scott Webster et al.
CANCER (2006)
The relationship between the preoperative systemic inflammatory response and cancer-specific survival in patients undergoing potentially curative resection for renal clear cell cancer
GWA Lamb et al.
BRITISH JOURNAL OF CANCER (2006)
Effector memory T cells, early metastasis, and survival in colorectal cancer
F Pagès et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Renal-cell carcinoma
HT Cohen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Clinical significance of programmed death-1 ligand-1 and programmed death-1 ligand-2 expression in human esophageal cancer
Y Ohigashi et al.
CLINICAL CANCER RESEARCH (2005)
C-reactive protein: A biomarker of survival in patients with metastatic renal cell carcinoma treated with subcutaneous interleukin-2 based immunotherapy
A Casamassima et al.
JOURNAL OF UROLOGY (2005)
Fusion cell vaccination of patients with metastatic breast and renal cancer induces immunological and clinical responses
D Avigan et al.
CLINICAL CANCER RESEARCH (2004)
The relationship between T-lymphocyte infiltration, stage, tumour grade and survival in patients undergoing curative surgery for renal cell cancer
EJ Bromwich et al.
BRITISH JOURNAL OF CANCER (2003)
Randomized study of high-dose and low-dose interleukin-2 in patients with metastatic renal cancer
JC Yang et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Effect of tumor-infiltrating lymphocyte subsets on prognosis and susceptibility to interferon therapy in patients with renal cell carcinoma
T Igarashi et al.
UROLOGIA INTERNATIONALIS (2002)
Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation
R Childs et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
分享论文
